MIMS Education
Role of long-term albumin for the treatment of cirrhosis
1 Point | 
50 Minutes | 
30 Nov 2025
Overview
About this course
Clinical management of decompensated cirrhosis, particularly when complicated by ascites, presents a substantial challenge. This e-module, presented by Professor Rosmawati Mohamed, provides a comprehensive overview of the role of long-term albumin (LTA) for the management of these complications. The module explores the pathophysiological mechanisms by which albumin modulates systemic inflammation and circulatory dysfunction, emphasizing its emerging role as a disease-modifying agent in cirrhosis. Through evidence-based insights and clinical data, the module underscores the importance of LTA in improving patient survival and mitigating cirrhosis-related complications. Additionally, it highlights current recommendations for the use of LTA in managing specific patient groups, such as those with refractory ascites, and the need for individualized treatment approaches.
Learning Objectives
Upon completion of this module, you should be able to:
- Understand the pathophysiology and complications of decompensated cirrhosis
- Comprehend the therapeutic role of LTA in reducing inflammation, oxidative stress, and circulatory dysfunction
- Identify the clinical benefits of LTA, including reduced complications, enhanced quality of life, and improved survival
- Recognize the importance of personalized LTA dosing to optimize patient outcomes
- Understand current recommendations for the use of LTA in managing patients with refractory ascites and the need for individualized treatment strategies
- Evaluate the cost-effectiveness and long-term benefits of LTA in clinical practice
CPD Author:
Prof. Dr. Rosmawati binti Mohamed1 CPD Point Available
- Score at least 80% in the multiple-choice quiz.
Sponsored by:
